Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Axalta Coating Systems (AXTA) Asset Writedowns and Impairment (2016 - 2023)

Axalta Coating Systems (AXTA) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $8.0 million as the latest value for Q2 2023.

For Q2 2023, Asset Writedowns and Impairment changed N/A year-over-year to $8.0 million; the TTM value through Mar 2024 reached $8.0 million, down 54.29%, while the annual FY2025 figure was $1.0 million, N/A changed from the prior year.
Asset Writedowns and Impairment hit $8.0 million in Q2 2023 for Axalta Coating Systems, up from $7.0 million in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $8.0 million in Q2 2023 and bottomed at $7.0 million in Q1 2023.